Unknown

Dataset Information

0

Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads.


ABSTRACT: Viral infections and reactivations remain a serious obstacle to successful hematopoietic stem cell transplantation (HSCT). When antiviral drug treatment fails, adoptive virus-specific T-cell transfer provides an effective alternative. Assuming that naive T cells (TN) are mainly responsible for GvHD, methods were developed to generate naive T-cell-depleted products while preserving immune memory against viral infections. We compared two major strategies to deplete potentially alloreactive T cells: CD45RA and CD62L depletion and analyzed phenotype and functionality of the resulting CD45RA-/CD62L- naive T-cell-depleted as well as CD45RA⁺/CD62L⁺ naive T-cell-enriched fractions in the CMV pp65 and IE1 antigen model. CD45RA depletion resulted in loss of terminally differentiated effector memory T cells re-expressing CD45RA (TEMRA), and CD62L depletion in loss of central memory T cells (TCM). Based on these differences in target cell-dependent and target cell-independent assays, antigen-specific T-cell responses in CD62L-depleted fraction were consistently 3⁻5 fold higher than those in CD45RA-depleted fraction. Interestingly, we also observed high donor variability in the CD45RA-depleted fraction, resulting in a substantial loss of immune memory. Accordingly, we identified donors with expected response (DER) and unexpected response (DUR). Taken together, our results showed that a naive T-cell depletion method should be chosen individually, based on the immunophenotypic composition of the T-cell populations present.

SUBMITTER: Mangare C 

PROVIDER: S-EPMC6471767 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads.

Mangare Caroline C   Tischer-Zimmermann Sabine S   Riese Sebastian B SB   Dragon Anna C AC   Prinz Immo I   Blasczyk Rainer R   Maecker-Kolhoff Britta B   Eiz-Vesper Britta B  

International journal of molecular sciences 20190320 6


Viral infections and reactivations remain a serious obstacle to successful hematopoietic stem cell transplantation (HSCT). When antiviral drug treatment fails, adoptive virus-specific T-cell transfer provides an effective alternative. Assuming that naive T cells (T<sub>N</sub>) are mainly responsible for GvHD, methods were developed to generate naive T-cell-depleted products while preserving immune memory against viral infections. We compared two major strategies to deplete potentially alloreact  ...[more]

Similar Datasets

| S-EPMC10605421 | biostudies-literature
| S-EPMC8465008 | biostudies-literature
| S-EPMC10676521 | biostudies-literature
| S-EPMC7378179 | biostudies-literature
| S-EPMC4739640 | biostudies-literature
| S-EPMC3043230 | biostudies-literature
| S-EPMC9954596 | biostudies-literature
| S-EPMC8603025 | biostudies-literature
| S-EPMC5535884 | biostudies-literature
| S-EPMC8184601 | biostudies-literature